within Pharmacolibrary.Drugs.ATC.J;

model J01DH03
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.9166666666666666e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.008199999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0048,
    k12             = 4.5,
    k21             = 4.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DH03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ertapenem is a broad-spectrum carbapenem antibiotic used to treat a variety of infections caused by susceptible Gram-positive and Gram-negative bacteria, including intra-abdominal infections, community-acquired pneumonia, skin and soft tissue infections, and urinary tract infections. It is approved and currently used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single intravenous dose.</p><h4>References</h4><ol><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2007). Comparative review of the carbapenems. <i>Drugs</i> 67(7) 1027–1052. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200767070-00006&quot;>10.2165/00003495-200767070-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17488146/&quot;>https://pubmed.ncbi.nlm.nih.gov/17488146</a></p></li><li><p>Jumpertz, M, et al., &amp; Cassir, N (2022). Subcutaneously administered antibiotics: a review. <i>The Journal of antimicrobial chemotherapy</i> 78(1) 1–7. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac383&quot;>10.1093/jac/dkac383</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36374566/&quot;>https://pubmed.ncbi.nlm.nih.gov/36374566</a></p></li><li><p>Albin, OR, et al., &amp; Pogue, JM (2023). Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 76(4) 745–749. DOI:<a href=&quot;https://doi.org/10.1093/cid/ciac784&quot;>10.1093/cid/ciac784</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36130230/&quot;>https://pubmed.ncbi.nlm.nih.gov/36130230</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DH03;
